Keynote Presentation: Showcasing Cabaletta Bio’s Rese-cel Data & Industry Implications to Progress CAR-T in Autoimmunity
Time: 9:30 am
day: Conference Day 1 P1
Details:
- Explore rese-cel, a CAR-T cell therapy, combating autoimmune diseases to provide insight into the future of autoimmune cell therapies
- Discuss how translational and mechanistic insights accelerated the design and development of rese-cel in autoimmunity
- Evaluate the depth of peripheral and tissue-level target cell depletion with rese-cel in patients with autoimmune disease
